[1]候学智,黄强.急性肺血栓栓塞症介入治疗现状[J].介入放射学杂志,2024,33(09):1027-1033.
　HOU Xuezhi,HUANG Qiang.Current status of interventional therapy for acute pulmonary thromboembolism[J].journal interventional radiology,2024,33(09):1027-1033.

点击复制

急性肺血栓栓塞症介入治疗现状()

PDF下载中关闭

• 
• 
• 

分享到：

参考文献/References:

［1］吕琴，何雅，高慎敏.肺栓塞患者合并阻塞性睡眠呼吸暂停发病率及危险因素Meta分析［J］.四川医学，2023，44：349-355.
［2］Lehnert P，Lange T，Moller CH，et al. Acute pulmonary embolism in a National Danish cohort：increasing incidence and decreasing mortality［J］. Thromb Haemost，2018，118：539-546.
［3］赵声远，王丽倩，贺爱兰，等.医院获得性肺血栓栓塞症的临床特征与危险因素分析［J］.中国普通外科杂志，2022，31：813-821.
［4］Tritschler T，Kraaijpoel N，Le Gal G，et al. Venous thromboembolism：advances in diagnosis and treatment［J］. JAMA，2018，320：1583-1594.
［5］Zhang X，Li W，Lin A，et al. Outcomes of catheter ablation of atrial tachyarrhythmia guided exclusively by activation mapping［J］. J Interv Card Electrophysiol，2023，66：1383-1389.
［6］林盼，田凌云，贺爱兰，等.静脉血栓栓塞症复发现状及风险评估工具研究进展［J］.中国普通外科杂志，2020，29：1391-1398.
［7］Chatterjee S，Chakraborty A，Weinberg I，et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality，major bleeding，and intracranial hemorrhage：a meta-analysis［J］. JAMA，2014，311：2414-2421.
［8］Wan S，Quinlan DJ，Agnelli G，et al. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism：a meta-analysis of the randomized controlled trials［J］. Circulation，2004，110：744-749.
［9］张静，闫盈盈，翟所迪.基于文献的中国肺栓塞患者药物治疗与国内指南符合程度的比较研究［J］.中国新药杂志，2020，29：831-835.
［10］Jaff MR，McMurtry MS，Archer SL，et al. Management of massive and submassive pulmonary embolism，iliofemoral deep vein thrombosis，and chronic thromboembolic pulmonary hypertension：a scientific statement from the American Heart Association［J］. Circulation，2011，123：1788-1830.
［11］Meyer G，Vicaut E，Danays T，et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism［J］. N Engl J Med，2014，370：1402-1411.
［12］Michaud E，Pan M，Aggarwal V. Catheter-based therapies in acute and chronic pulmonary embolism［J］. Curr Opin Cardiol，2021，36：704-710.
［13］Marti C，John G，Konstantinides S，et al. Systemic thrombolytic therapy for acute pulmonary embolism：a systematic review and meta-analysis［J］. Eur Heart J，2015，36：605-614.
［14］杜昌，余剑波，朱继红.存在溶栓禁忌证的肺血栓栓塞症患者治疗策略分析［J］.中国全科医学，2018，21：194-198.
［15］Abrahams-van Doorn PJ，Hartmann IJ. Cardiothoracic CT：one-stop-shop procedure? Impact on the management of acute pulmonary embolism［J］. Insights Imaging，2011，2：705-715.
［16］Maughan BC，Frueh L，McDonagh MS，et al. Outpatient treatment of low-risk pulmonary embolism in the era of direct oral anticoagulants：a systematic review［J］. Acad Emerg Med，2021，28：226-239.
［17］Aujesky D，Roy PM，Verschuren F，et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism：an international，openlabel，randomised，non-inferiority trial［J］. Lancet，2011，378：41-43.
［18］Brailovsky Y，Allen S，Masic D，et al. Risk stratification of acute pulmonary embolism［J］. Curr Treat Options Cardiovasc Med，2021，23：48.
［19］赵辉，胡红耀，饶珉，等.经皮机械性血栓清除术同期联合髂静脉支架置入治疗髂静脉压迫综合征并发急性下肢深静脉血栓形成［J］.临床放射学杂志，2021，40：806-810.
［20］Allen S，Chan L，Masic D，et al. Comparison of outcomes in catheter-directed versus ultrasound-assisted thrombolysis for management of submassive pulmonary embolism［J］. Thromb Res，2021，202：96-99.
［21］Zuin M，Kuo WT，Rigatelli G，et al. Catheter-directed therapy as a first-line treatment strategy in hemodynamically unstable patients with acute pulmonary embolism：yes or no?［J］. Int J Cardiol，2016，225：14-15.
［22］Kucher N，Boekstegers P，Müller OJ，et al. Randomized，controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism［J］. Circulation，2014，129：479-486.
［23］Piazza G，Hohlfelder B，Jaff MR，et al. A prospective，single-arm，multicenter trial of ultrasound-facilitated，catheter-directed，low-dose fibrinolysis for acute massive and submassive pulmonary embolism：the SEATTLE Ⅱ study［J］. JACC Cardiovasc Interv，2015，8：1382-1392.
［24］Kuo WT，Banerjee A，Kim PS，et al. Pulmonary embolism response to fragmentation，embolectomy，and catheter thrombolysis（PERFECT）：initial results from a prospective multicenter registry［J］. Chest，2015，148：667-673.
［25］Beyer SE，Shanafelt C，Pinto DS，et al. Utilization and outcomes of thrombolytic therapy for acute pulmonary embolism：a nationwide cohort study［J］. Chest，2020，157：645-653.
［26］George B，Parazino M，Omar HR，et al. A retrospective comparison of survivors and non-survivors of massive pulmonary embolism receiving veno-arterial extracorporeal membrane oxygenation support［J］. Resuscitation，2018，122：1-5.
［27］Guo A，Foraker R，White P，et al. Using electronic health records and claims data to identify high-risk patients likely to benefit from palliative care［J］. Am J Manag Care，2021，27：e7-e15.
［28］Pasha AK，Siddiqui MU，Siddiqui MD，et al. Catheter directed compared to systemically delivered thrombolysis for pulmonary embolism：a systematic review and meta-analysis［J］. J Thromb Thrombolysis，2022，53：454-466.
［29］Tapson VF，Sterling K，Jones N，et al. A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism：the OPTALYSE PE trial［J］. JACC Cardiovasc Interv，2018，11：1401-1410.
［30］Rothschild DP，Goldstein JA，Ciacci J，et al. Ultrasound-accelerated thrombolysis（USAT）versus standard catheter-directed thrombolysis（CDT）for treatment of pulmonary embolism：a retrospective analysis［J］. Vasc Med，2019，24：234-240.
［31］Avgerinos ED，Jaber W，Lacomis J，et al. Randomized trial comparing standard versus ultrasound-assisted thrombolysis for submassive pulmonary embolism：the SUNSET sPE trial［J］. JACC Cardiovasc Interv，2021，14：1364-1373.
［32］Bashir R，Foster M，Iskander A，et al. Pharmacomechanical catheter-directed thrombolysis with the bashir endovascular catheter for acute pulmonary embolism：the RESCUE study［J］. JACC Cardiovasc Interv，2022，15：2427-2436.
［33］Schmitz-Rode T，Janssens U，Duda SH，et al. Massive pulmonary embolism：percutaneous emergency treatment by pigtail rotation catheter［J］. J Am Coll Cardiol，2000，36：375-380.
［34］Tu T，Toma C，Tapson VF，et al. A prospective，single-arm，multicenter trial of catheter-directed mechanical thrombectomy for intermediate-risk acute pulmonary embolism：the FLARE study［J］. JACC Cardiovasc Interv，2019，12：859-869.
［35］Toma C，Khandhar S，Zalewski AM，et al. Percutaneous thrombectomy in patients with massive and very high-risk submassive acute pulmonary embolism［J］. Catheter Cardiovasc Interv，2020，96：1465-1470.
［36］De Gregorio MA，Guirola JA，Kuo WT，et al. Catheter-directed aspiration thrombectomy and low-dose thrombolysis for patients with acute unstable pulmonary embolism：prospective outcomes from a PE registry［J］. Int J Cardiol，2019，287：106-110.
［37］Sista AK，Horowitz JM，Tapson VF，et al. Indigo aspiration system for treatment of pulmonary embolism：results of the EXTRACT-PE trial［J］. JACC Cardiovasc Interv，2021，14：319-329.
［38］Al-Hakim R，Park J，Bansal A，et al. Early experience with AngioVac aspiration in the pulmonary arteries［J］. J Vasc Interv Radiol，2016，27：730-734.
［39］Kuo WT，Gould MK，Louie JD，et al. Catheter-directed therapy for the treatment of massive pulmonary embolism：systematic review and meta-analysis of modern techniques［J］. J Vasc Interv Radiol，2009，20：1431-1440.
［40］Das S，Das N，Serota H，et al. A retrospective review of patients with massive and submassive pulmonary embolism treated with AngioJet rheolytic thrombectomy with decreased complications due to changes in thrombolytic use and procedural modifications［J］. Vascular，2018，26：163-168.
［41］Latacz P，Simka M，Brzegowy P，et al. Treatment of high-and intermediate-risk pulmonary embolism using the AngioJet percutaneous mechanical thrombectomy system in patients with contraindications for thrombolytic treatment：a pilot study［J］. Wideochir Inne Tech Malo Inwazyjne，2018，13：233-242.
［42］公茂峰，何旭，楼文胜，等.流变式与手动血栓清除术介入治疗急性髂股静脉血栓形成的疗效比较［J］.中华普通外科杂志，2018，33：388-392.